Trading asset-backed securities are available in pharmaceutical industry

Published: 2009-04-09 06:57:00

Updated: 2009-04-09 06:57:00

Starep Corporation announced that it has developed a new asset-backed security (ABS) to pool the underlying assets of 30 billion won in the account receivables of pharmaceutical firms.

The company said that pooling the assets allows them to be sold to general investors, a process called securi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK